Skip to content

Charles River Laboratories CRL Future pension and postretirement benefit obligations

Future pension and postretirement benefit obligations at other companies

General Motors logo
General MotorsGM
$4.71B-18.3%
Carrier Global logo
Carrier GlobalCARR
$165M-8.3%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$173M+3.6%
Marsh logo
MarshMRSH
$752M-9.6%
Sherwin-Williams logo
Sherwin-WilliamsSHW
$131.6M+9.0%
Delta Air Lines logo
Delta Air LinesDAL
$3.12B-0.1%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's future pension and postretirement benefit obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's future pension and postretirement benefit obligations?
Charles River Laboratories (CRL) reported future pension and postretirement benefit obligations of $66.3M in Q1 2026.
What is the long-term trend for Charles River Laboratories's future pension and postretirement benefit obligations?
Over 2 years (2020 to 2025), Charles River Laboratories's future pension and postretirement benefit obligations has grown at a -4.0% compound annual growth rate (CAGR), from $74.23M to $68.44M.